Sign in with Google. Opens in new tab
ENTITY
Pfizer Inc

Pfizer Inc (PFE US)

330
Analysis
Health CareUnited States
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
more
bullishPfizer Inc
10 May 2025 09:00

Pfizer’s $15 Billion War Chest: What Will They Buy After the Danuglipron Failure?

Pfizer recently reported its first-quarter 2025 financial results, providing an overall positive snapshot of its performance within a challenging...

Logo
477 Views
Share
bearishPfizer Inc
16 Jan 2025 22:56Issuer-paid

PFIZER INC. Equity Research Flash Note - December 13, 2024

The company’s annual revenue was $58,496 million in 2023 compared to $100,330 million in 2022, post- ing a significant decrease by 41.7%.

bearishPfizer Inc
24 Oct 2024 07:48Podcast

An activist tried to take on Pfizer. Then things got messy

Pfizer, a pharmaceutical giant, faces challenges post-pandemic including a failed acquisition and investor doubts about its future growth potential.

Logo
844 Views
Share
17 Nov 2024 01:29

Who Are Leading the Charge in the RNAissance of Medicine

RNA therapeutics: We analyze the field and spotlight top players driving this precision medicine, for tackling rare diseases with innovative solutions

Logo
333 Views
Share
04 Nov 2024 08:39

Dow Jones Industrial Avg Nov24 Rebalance - Sherwin Williams (SHW) Could Get Jiggy

The DJIA (Dow30) is an odd anachronism. Price-weighted. Rebalances when it wants. No ranking system. Just a committee and some vague inputs. This...

Logo
386 Views
Share
x